2-Amino-1,3-thiazole-5-carboxylic acid → N1-(2-Aminothiazol-5-ylcarbonyl)-N2-(4-tert-butylbenzoyl)-1,2-benzenediamine
반응식
[NH2:1][C:2]1[S:3][C:4]([C:7]([OH:9])=O)=[CH:5][N:6]=1.[C:10]([C:14]1[CH:29]=[CH:28][C:17]([C:18]([NH:20][C:21]2[C:22]([NH2:27])=[CH:23][CH:24]=[CH:25][CH:26]=2)=[O:19])=[CH:16][CH:15]=1)([CH3:13])([CH3:12])[CH3:11]>>[NH2:1][C:2]1[S:3][C:4]([C:7]([NH:27][C:22]2[C:21]([NH:20][C:18](=[O:19])[C:17]3[CH:28]=[CH:29][C:14]([C:10]([CH3:12])([CH3:11])[CH3:13])=[CH:15][CH:16]=3)=[CH:26][CH:25]=[CH:24][CH:23]=2)=[O:9])=[CH:5][N:6]=1참가 물질
3
실험 절차
Using the procedure described in Example 102, Part A, 2-aminothiazole-5-carboxylic acid (1.0 mmol) and N1-(4-tert-butylbenzoyl)-1,2-benzenediamine (1.5 mmol) yielded 50 mg (13%) of the title compound.
출처 및 근거
- ORD 기록
- ord-3fabfeaac1d745c493173b1696bfeda8
- 출처 데이터셋
- uspto-grants-2001_11
- 특허 번호
- US06313122B1
반응 노트
불러오는 중…